New supplement aims to ease Runners' knee pain
NCT ID NCT07561203
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a daily 40 mg dose of Collavant n2 can reduce knee discomfort in healthy, active men aged 40-65 who run regularly. Eighty amateur male runners with exercise-induced knee pain will take either the supplement or a placebo for a period, and their pain levels will be measured before and after running. The goal is to see if this supplement helps ease joint pain caused by physical activity.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY ADULT MALE are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Universidad Politecnica de Madrid
RECRUITINGMadrid, Madrid, 28040, Spain
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a simple vest make breathing easier?
- Chilly workouts may alter what you eat, small study suggests
- New Parkinson's drug MF1 enters first human safety trial
- AI-Powered training cuts hamstring injury risk in pro footballers
- Beta-Alanine boost for cyclists? new study reveals mixed results
- New Egg-Maturing technique could help women with low IVF success